Ditchcarbon
  • Customers
  1. Organizations
  2. Cambrex Karlskoga
Public Profile
Pharmaceutical Preparation Manufacturing
SE
updated 10 days ago

Cambrex Karlskoga

Company website

Cambrex Karlskoga, a prominent subsidiary of Cambrex Corporation, is headquartered in Karlskoga, Sweden. Established in 1981, the company has become a key player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. With a strong focus on quality and compliance, Cambrex Karlskoga has achieved significant milestones, including certifications from regulatory bodies such as the FDA and EMA. The company offers a range of services, including custom synthesis and process development, which are distinguished by their commitment to innovation and efficiency. Cambrex Karlskoga's strategic location in Sweden allows it to serve a diverse clientele across Europe and North America, solidifying its position as a trusted partner in the pharmaceutical supply chain. With a reputation for excellence, Cambrex Karlskoga continues to contribute to advancements in drug development and manufacturing.

DitchCarbon Score

How does Cambrex Karlskoga's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Cambrex Karlskoga's score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Cambrex Karlskoga's reported carbon emissions

In 2023, Cambrex Karlskoga reported total carbon emissions of approximately 2,849,000 kg CO2e for Scope 1 and 2 combined, alongside about 53,330,000 kg CO2e for Scope 3 emissions. This marks a reduction from 2022, where Scope 1 and 2 emissions were about 2,607,000 kg CO2e and Scope 3 emissions were approximately 55,540,000 kg CO2e. The company has set ambitious climate commitments, aiming for a 52% reduction in Scope 1 and 2 emissions and a 42% reduction in Scope 3 emissions by 2030, using 2018 and 2020 as baseline years, respectively. These targets are aligned with the Science Based Targets initiative (SBTi), which confirms that Cambrex Corporation, the parent company, is committed to reducing absolute Scope 1 and 2 GHG emissions by 51.6% by 2030. The company also aims to cut Scope 3 emissions from purchased goods and services, fuel- and energy-related activities, and upstream transportation and distribution by 42% by the same year. Cambrex Karlskoga's emissions data and reduction targets are part of a broader corporate strategy to address climate change and enhance sustainability within the pharmaceuticals, biotechnology, and life sciences sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201820192020202120222023
Scope 1
-
-
-
-
-
-
-
Scope 2
-
-
-
-
-
-
-
Scope 3
-
-
-
00,000,000
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cambrex Karlskoga's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cambrex Karlskoga is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cambrex Karlskoga is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Novozymes

DK
•
Chemicals nec
Updated 1 day ago

Siegfried Holding

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

PRA Health Sciences, Inc.

US
•
Research and development services (73)
Updated 9 days ago

WuXi PharmaTech (Cayman) Inc.

CN
•
Research and development services (73)
Updated 9 days ago

ANI Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Phastar

GB
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy